Citations

Mayo Clinic

Showing 10 of 108602 citations.

Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS‐diarrhoea and functional diarrhoea
Vijayvargiya, Prakhar , Camilleri, Michael , Carlson, Paula, Lueke, Alan J., O’Neill, Jessica, Burton, Duane D. , Busciglio, Irene, Camilleri, M , Donato, Leslie J.

Alimentary Pharmacology & Therapeutics | July 10, 2017 | Volume: 46 | Issue: 6 | Pages: 581-588

10.1111/apt.14214 | PMID 28691284 Get It

SummaryBackgroundThe serum biomarkers, elevated 7αC4 (C4) and decreased FGF19, have been proposed as screening tests for bile acid diarrhoea.AimTo analyse prevalence, specificity and reproducibility of fasting C4 and FGF19 in identifying bile acid diarrhoea in patients with irritable bowel syndrome with predominant diarrhoea or functional diarrhoea (summarised as IBS‐D).MethodsWe prospectively studied fasting serum C4 and FGF19 in 101 IBS‐D patients; we reviewed data from 37 of the 101 patients with prior fasting serum C4 and FGF19 and from 30 of the 101 patients with prior faecal bile acids per 48 hours. We compared results with normal values (C4 ≥52.5 ng/mL [n=184], FGF‐19 ≤61.7 pg/mL [n=50]). We used Spearman correlation and Bland‐Altman plots to appraise reproducibility.ResultsAmong the 101 patients, there was a negative correlation between serum C4 and FGF19 (Rs=−.342, P=.0005). Bile acid diarrhoea was diagnosed in 10 patients based on elevated serum C4 levels (mean 23.5±23.1 [SD] ng/mL) and 21 patients based on decreased FGF19 levels (121.6±84.2 pg/mL). With replicate tests in patients with stable IBS‐D, 78% of C4 and 70% of FGF19 measurements remained concordant, with 3% and 11% respectively consistently positive for bile acid diarrhoea in the 101 patients. Compared to 48 hours faecal bile acids, specificity for C4 and FGF19 was 83% and 78%, respectively. Bland‐Altman plots demonstrated greater reliability of C4 than FGF19.ConclusionsAmong 101 patents with IBS‐D, fasting FGF19 and C4 levels had good specificity and negative predictive value, suggesting utility as screening tests to exclude bile acid diarrhoea.
Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein‐coupled receptor structure and function
Desai, Aditya J. , Miller, Laurence J. , Miller, Laurence J

British Journal of Pharmacology | July 10, 2017 | Volume: 175 | Issue: 21 | Pages: 4009-4025

10.1111/bph.13943 | PMID 28691227 Get It

Drug development targeting GPCRs often utilizes model heterologous cell expression systems, reflecting an implicit assumption that the membrane environment has little functional impact on these receptors or on their responsiveness to drugs. However, much recent data have illustrated that membrane components can have an important functional impact on intrinsic membrane proteins. This review is directed toward gaining a better understanding of the structure of the plasma membrane in health and disease, and how this organelle can influence GPCR structure, function and regulation. It is important to recognize that the membrane provides a potential mode of lateral allosteric regulation of GPCRs and can affect the effectiveness of drugs and their biological responses in various disease states, which can even vary among individuals across the population. The type 1 cholecystokinin receptor is reviewed as an exemplar of a class A GPCR that is affected in this way by changes in the plasma membrane.Linked ArticlesThis article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visithttp://onlinelibrary.wiley.com/doi/10.1111/bph.v175.21/issuetoc
Ethanol‐induced steatosis involves impairment of lipophagy, associated with reduced Dynamin2 activity
Rasineni, Karuna , Donohue, Terrence M. , Thomes, Paul G. , Li, Yang , Tuma, Dean J., McNiven, Mark A. , Casey, Carol A.

Hepatology Communications | July 10, 2017 | Volume: 1 | Issue: 6 | Pages: 501-512

10.1002/hep4.1063 | PMID 29152606 Get It

Lipid droplets (LDs), the organelles central to alcoholic steatosis, are broken down by lipophagy, a specialized form of autophagy. Here, we hypothesize that ethanol administration retards lipophagy by down‐regulating dynamin 2 (Dyn2), a protein that facilitates lysosome re‐formation, contributing to hepatocellular steatosis. Primary hepatocytes were isolated from male Wistar rats fed Lieber–DeCarli control or ethanol (EtOH) liquid diets for 6‐8 weeks. Hepatocytes were incubated in complete medium (fed) or nutrient‐free medium (fasting) with or without the Dyn2 inhibitor dynasore or the Src inhibitor SU6656. Phosphorylated (active) forms of Src and Dyn2 and markers of autophagy were quantified using western blot analysis. Colocalization of LDs with autophagic machinery was determined using confocal microscopy. In hepatocytes from pair‐fed rats, LD breakdown was accelerated during fasting, as judged by smaller LDs and lower triglyceride (TG) content when compared with hepatocytes in complete media. Fasting‐induced TG loss in control hepatocytes was significantly blocked by either SU6656 or Dynasore. Compared with controls, hepatocytes from EtOH‐fed rats had 66% and 40% lower content of phosphorylated Src (pSrc) and phosphorylated Dyn2 (pDyn2), respectively, coupled with a lower rate of fasting‐induced TG loss. This slower rate of fasting‐induced TG loss was blocked in cells coincubated with Dynasore. Microscopic examination of EtOH‐fed rat hepatocytes revealed increased colocalization of the autophagosome marker LC3 on LDs with a concomitant decrease in lysosome marker LAMP1. Whole livers and LD fractions of EtOH‐fed rats exhibited simultaneous increase in LC3II and p62 over that of controls, indicating a block in lipophagy. Conclusion: Chronic ethanol administration slowed the rate of hepatocyte lipophagy, owing in part to lower levels of phosphorylated Src kinase available to activate its substrate, Dyn2, thereby causing depletion of lysosomes for LD breakdown. (Hepatology Communications 2017;1:501–512)
Central cannulation strategy for extent I thoracoabdominal aneurysm repair of chronic type B aortic dissection
Hobbs, Reilly D. , Wallen, Tyler , Komlo, Caroline , Moeller, Patrick , Pochettino, Alberto , Bavaria, Joseph E. , Vallabhajosyula, Prashanth

Journal of Cardiac Surgery | July 10, 2017 | Volume: 32 | Issue: 8 | Pages: 494-499

10.1111/jocs.13171 | PMID 28691213 Get It

Specificity of peer difficulties to social anxiety in early adolescence: categorical and dimensional analyses with clinical and community samples
Early, Martha C., Biggs, Bridget K. , Makanui, Kalani, Legerski, John‐Paul , Allen, Jason Van , Elledge, Allison R., Whiteside, Stephen P. H. , Whiteside, Stephen P., Biggs, Bridget K

Anxiety, Stress, & Coping | July 10, 2017 | Volume: 30 | Issue: 6 | Pages: 647-660

10.1080/10615806.2017.1348296 | PMID 28689447 Get It

Mayo's Older American Normative Studies: Separate Norms for WMS-R Logical Memory Stories
Wong, Jennifer S. , Ivnik, Robert J., Malec, James F. , Smith, Glenn E.

Assessment | July 9, 2017 | Volume: 4 | Issue: 1 | Pages: 79-86

10.1177/107319119700400111 Get It

The present analyses provide separate norms for persons ages 56 to 93 years for each story from the Logical Memory subtests of the revised edition of the Wechsler Memory Scale. Norms for immediate (I) and delayed (II) trials are presented. Following our past Mayo's Older Americans Normative Studies (MOANS) methods, we established the need for age adjustments (but not education adjustments) based on multiple regression analyses. Norms with added reliability based on the method of overlapping intervals were developed. We present means and standard deviations for 3-year interval age groups from age 61 to 88 years.
Prolonged Inhibition of Presynaptic Catecholamine Synthesis With α-Methyl-Para-Tyrosine Attenuates the Circadian Rhythm of Human TSH Secretion
Zimmermann, Ralf C., Krahn, Lois E., Klee, George G., Ditkoff, Edward C., Sauer, Mark V. , Ory, Steven J.

Journal of the Society for Gynecologic Investigation | July 9, 2017 | Volume: 8 | Issue: 3 | Pages: 174-178

10.1177/107155760100800309 Get It

Depression before and after diagnosis of multiple sclerosis
Sullivan, Michael J., Mikail, Samuel F. , Edgley, Krista, Sullivan, M JL, Weinshenker, Brian G.

Multiple Sclerosis Journal | July 9, 2017 | Volume: 1 | Issue: 2 | Pages: 104-108

10.1177/135245859500100208 | PMID 9345460 Get It

Depression was examined in 45 patients evaluated within 2 months of diagnosis of MS. At the time of testing, 40% of the MS sample met the diagnostic criteria for major depression, 22% had adjustment disorder with depressed mood and 37% showed no evidence of mood disorder. Personal and family history of depression in patients with MS was also examined and compared with a sample of patients with chronic low back pain (CLBP) who were matched for age, gender, marital and employment status and current level of depression. Fifty-two per cent of patients whit MS reported experiencing a depressive episode before the onset of MS compared with 17% of patients with CLBP (P<0.001). Sixteen patients with MS (35%) reported family history (parent or sibling) of treatment for depression compared with seven (15%) of patients with CLBP (P<0.05). MS patients with a history of depression reported more initial symptoms than MS patients without a history of depression. Clinical and theoretical implications of the findings are discussed.
Prorating IQ Scores for Older Adults: Validation of a Seven-Subtest WAIS-R with the Mayo Older Americans Normative Sample
Schretlen, David J. , Ivnik, Robert J.

Assessment | July 9, 2017 | Volume: 3 | Issue: 4 | Pages: 411-416

10.1177/107319119600300406 Get It

Concurrent validity of a seven-subtest short form (7SF) of the revised edition of the Wechsler Adult Intelligence Scale (WAIS-R) was examined in 733 cognitively normal adults between 56 and 99 years of age who participated in Mayo's Older Americans Normative Studies (MOANS). Pearson correlation coefficients between actual and prorated MAYO Verbal, Performance, and Full Scale IQ scores ranged from r =. 93 to r =. 97. Actual and prorated FSIQ scores differed by 6 points or less for 98% of participants, and the observed deviations did not vary as a function of age. These results support the use of this WAIS-R short form to prorate MAYO IQ scores for older adults.
Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
Dioverti, M. Veronica , Lahr, Brian D. , Germer, Jeffrey J., Yao, Joseph D. , Gartner, Michelle L, Razonable, Raymund R. , Dioverti, Maria Veronica

Open Forum Infectious Diseases | July 8, 2017 | Volume: 4 | Issue: 3 | Pages: No page available

10.1093/ofid/ofx143 | PMID 28852681 Get It

Abstract Background Quantification of cytomegalovirus (CMV) deoxyribonucleic acid (DNA) has important diagnostic, prognostic, and therapeutic implications in the management of transplant recipients. We aimed to assess a viral load in plasma and whole blood that distinguishes CMV disease from asymptomatic infection in a cohort of solid organ and hematopoietic stem cell transplantation. Methods We prospectively measured and compared CMV viral load in paired plasma and whole blood samples collected from transplant recipients with CMV infection and disease. Cytomegalovirus viral loads were determined by a commercially available US Food and Drug Administration-approved quantitative assay (COBAS AmpliPrep/COBAS TaqMan CMV Test [CAP/CTM CMV]) calibrated to the first World Health Organization International Standard for CMV DNA quantification. Results Moderate agreement of CMV viral load was observed between plasma and whole blood, with 31% of samples having discordant findings, particularly among samples with low DNA levels. Among the subset of samples where both paired samples had quantifiable levels, we observed a systematic bias that reflected higher viral load in whole blood compared with plasma. Based on receiver operating curve analysis, an initial plasma CMV viral load threshold of 1700 IU/mL in solid organ transplant recipients (sensitivity 80%, specificity 74%) and 1350 IU/mL in allogeneic hematopoietic stem cell transplant recipients (sensitivity 87%, specificity 87%) distinguished CMV disease and asymptomatic infection. Conclusions This study identifies standardized viral load thresholds that distinguish CMV disease from asymptomatic infection using CAP/CTM CMV assay. We propose these thresholds as potential triggers to be evaluated in prospective studies of preemptive therapy. Plasma was better than whole blood for measuring viral load using the CAP/CTM CMV assay.